In this Review, the authors discuss the development of screening tools, outcome measures and new pharmaceutical interventions for managing patients with psoriatic arthritis (PsA). Screening tools are suggested to enable referral from dermatology clinics to rheumatologists for the diagnosis of patients early in the course of disease, and to help identify the best drugs to treat this heterogeneous disease. The authors also discuss the distinctions and similarities of 'tight control' and a treat-to-target approach for the management of PsA.
- Ignazio Olivieri
- Salvatore D'Angelo
- Angela Padula
